87 related articles for article (PubMed ID: 17050794)
61. Association of NAT2 genetic polymorphism with the efficacy of Neurotropin® for the enhancement of aggrecan gene expression in nucleus pulposus cells: a pilot study.
Nakai T; Sakai D; Nakamura Y; Horikita N; Matsushita E; Naiki M; Watanabe M
BMC Med Genomics; 2021 Mar; 14(1):79. PubMed ID: 33706752
[TBL] [Abstract][Full Text] [Related]
62. Diet, Exercise, Lifestyle, and Mental Distress among Young and Mature Men and Women: A Repeated Cross-Sectional Study.
Begdache L; Sadeghzadeh S; Derose G; Abrams C
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374693
[TBL] [Abstract][Full Text] [Related]
63. Pharmacotherapy of Pain in the Older Population: The Place of Opioids.
Prostran M; Vujović KS; Vučković S; Medić B; Srebro D; Divac N; Stojanović R; Vujović A; Jovanović L; Jotić A; Cerovac N
Front Aging Neurosci; 2016; 8():144. PubMed ID: 27378916
[TBL] [Abstract][Full Text] [Related]
64. Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes.
Jeong H
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):689-99. PubMed ID: 20367533
[TBL] [Abstract][Full Text] [Related]
65. Opioids for the treatment of chronic non-cancer pain in older people.
Gianni W; Ceci M; Bustacchini S; Corsonello A; Abbatecola AM; Brancati AM; Assisi A; Scuteri A; Cipriani L; Lattanzio F
Drugs Aging; 2009 Dec; 26 Suppl 1():63-73. PubMed ID: 20136170
[TBL] [Abstract][Full Text] [Related]
66. The clinical implications of ageing for rational drug therapy.
Shi S; Mörike K; Klotz U
Eur J Clin Pharmacol; 2008 Feb; 64(2):183-99. PubMed ID: 18180915
[TBL] [Abstract][Full Text] [Related]
67. Substrates of human cytochromes P450 from families CYP1 and CYP2: analysis of enzyme selectivity and metabolism.
Lewis DF; Lake BG; Dickins M
Drug Metabol Drug Interact; 2004; 20(3):111-42. PubMed ID: 15508429
[TBL] [Abstract][Full Text] [Related]
68. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.
Frye RF; Branch RA
Br J Clin Pharmacol; 2002 Feb; 53(2):155-62. PubMed ID: 11851639
[TBL] [Abstract][Full Text] [Related]
69. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
[TBL] [Abstract][Full Text] [Related]
70. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
[TBL] [Abstract][Full Text] [Related]
71. In vivo modulation of CYP enzymes by quinidine and rifampin.
Branch RA; Adedoyin A; Frye RF; Wilson JW; Romkes M
Clin Pharmacol Ther; 2000 Oct; 68(4):401-11. PubMed ID: 11061580
[TBL] [Abstract][Full Text] [Related]
72. Effects of Angelicae tenuissima radix, Angelicae dahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteers.
Yi S; Cho JY; Lim KS; Kim KP; Kim J; Kim BH; Hong JH; Jang IJ; Shin SG; Yu KS
Basic Clin Pharmacol Toxicol; 2009 Oct; 105(4):249-56. PubMed ID: 19422358
[TBL] [Abstract][Full Text] [Related]
73. Effect of conjugated equine estrogens on oxidative metabolism in middle-aged and elderly postmenopausal women.
O'Connell MB; Frye RF; Matzke GR; St Peter JV; Willhite LA; Welch MR; Kowal P; LaValleur J
J Clin Pharmacol; 2006 Nov; 46(11):1299-307. PubMed ID: 17050794
[TBL] [Abstract][Full Text] [Related]
74. How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo?
Tanaka E; Kurata N; Yasuhara H
J Clin Pharm Ther; 2003 Jun; 28(3):157-65. PubMed ID: 12795773
[TBL] [Abstract][Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]